Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,880 total articles
Portillo's Inc. released its first quarter 2026 financial results showing a 3.5% revenue increase to $182.6 million driven by new restaurant openings. However, same-restaurant sales declined slightly, and the company reported a net loss of $0.5 million compared to net income in the prior year. Operating income and Adjusted EBITDA both fell due to h…
Madrigal Pharmaceuticals announced an exclusive global license agreement to acquire ARO-PNPLA3, a clinical-stage siRNA asset targeting the PNPLA3 gene, a key genetic driver of Metabolic dysfunction-associated steatohepatitis (MASH). The addition enhances Madrigal's precision medicine strategy in MASH treatment, particularly benefiting Hispanic popu…
Apollo Global Management announced the final close of Apollo Hybrid Value Fund III, raising approximately $6.5 billion. The fund attracted a wide range of global institutional investors and focuses on hybrid capital strategies that blend debt and equity features to provide flexible, partnership-oriented investment solutions. This fund follows two p…
Picard Medical, Inc., listed on NYSE American as PMI, announced the pricing of a $5 million offering consisting of common stock, pre-funded warrants, and common warrants to institutional investors. The proceeds will be used for working capital, general corporate purposes, and to pay down senior secured notes and working capital loans. The offering …
Powell Industries, a leading provider of custom engineered electrical energy management solutions, declared a quarterly cash dividend of $0.09 per share payable June 17, 2026, to shareholders of record May 20, 2026. The company serves major industries including oil and gas, electric utilities, and industrial markets.
Enphase Energy, Inc., a leader in microinverter-based solar and energy storage systems, will hold its 2026 Annual Meeting of Stockholders on May 13, 2026, at its headquarters in Fremont, California. The meeting includes a CEO presentation by Badri Kothandaraman, accessible online and by phone. Additional details are provided in the company's proxy …
Septerna, Inc., a clinical-stage biotech company specializing in GPCR drug discovery, announced that its CEO Jeffrey Finer will present at the Bank of America Securities Health Care Conference on May 12, 2026. The presentation will be webcast live and archived on the company's website. Septerna focuses on developing novel oral small molecule therap…
Zentalis Pharmaceuticals announced dosing of the first patient in its global Phase 3 ASPENOVA trial evaluating azenosertib, a first-in-class WEE1 inhibitor, against standard chemotherapy in Cyclin E1-positive platinum-resistant ovarian cancer patients. The trial supports a confirmatory study to complement the ongoing Phase 2 DENALI trial aiming for…
IZEA Worldwide, a leading influencer marketing company, announced its financial results conference call for first quarter 2026 will be held on May 12, 2026. The call will be hosted by the CEO and CFO and include a Q&A session. Investors are invited to attend via webcast or phone, with a replay available for a week. The company highlights its positi…
Neuronetics, Inc. announced its Q1 2026 financial results showing an 8% increase in total revenues to $34.5 million driven by a 15% growth in U.S. clinic revenue. The company reduced operational cash burn and operating expenses, while expanding access to NeuroStar Advanced Therapy through new payer policies. Despite a net loss, improved cash flow a…
Core AI Holdings has appointed Sonali Garg, co-founder and COO of Allianca Group and former Meta data center leader, to its advisory board. This move enhances Core AI's execution capabilities as it advances its AI-ready data center platform in strategic partnership with Allianca, which specializes in rapid and scalable data center delivery. Garg br…
Enovix Corporation announced the appointment of Steve Bakos as Senior Vice President of Worldwide Sales to support the commercialization and scaling of its advanced silicon-anode lithium-ion batteries. This leadership addition comes at a pivotal time as Enovix aligns with a lead smartphone customer on a silicon-specific qualification framework, aim…
Nexentis Technologies Inc., through its wholly owned subsidiary MitoCareX Bio Ltd., announced the official U.S. trademark registration of its proprietary algorithm platform MITOLINE™, designed to advance mitochondrial drug discovery by enabling robust 3D modeling of mitochondrial carrier proteins. This milestone strengthens the company’s drug disco…
Nuvectis Pharma reported its financial results for Q1 2026 and provided updates on its clinical-stage oncology drug NXP900. The Phase 1b trial continues enrolling patients in the US, with preclinical data showing promising synergy of NXP900 combined with RAS inhibitor sotorasib in lung cancer models. The company maintains financial discipline, with…
GD Culture Group Limited announced the receipt of a non-binding proposal from a consortium to acquire all outstanding shares not already owned by the consortium for $10.75 per share in cash, representing a premium of approximately 169% over recent trading prices. The Board plans to evaluate the offer and consider forming a special committee to nego…
Willis Towers Watson (WTW) has completed its acquisition of UK workplace pension and savings provider Cushon, following regulatory approval. This acquisition solidifies WTW's position as the fourth largest master trust provider in the UK defined contribution workplace pensions market, managing over £30 billion in assets for 1.2 million members. The…
Cytokinetics announced that the pivotal Phase 3 ACACIA-HCM trial of aficamten met both of its primary endpoints, showing statistically significant improvements in symptoms and exercise capacity in patients with symptomatic non-obstructive hypertrophic cardiomyopathy (HCM). The drug demonstrated consistent benefits across key secondary measures with…
Telesat announced its Q1 2026 financial results showing a 25% revenue decline to CAD 87 million largely due to broadcast contract non-renewals in the GEO segment, while investing heavily (CAD 171 million) in its LEO Telesat Lightspeed constellation development targeted for commercial service launch around Q1 2028. The company reported a net loss of…
Rumble Inc. has received the final regulatory approval from the UAE Ministry of Economy for its proposed business combination with Northern Data AG. The transaction has seen significant shareholder participation, with 77% of Northern Data shares secured under tender or support agreements. The combined entity seeks to leverage Northern Data's high-p…
Surgery Partners, Inc. announced its Q1 2026 financial results, showing a 4.5% year-over-year revenue increase to $810.9 million, driven by a 4.4% rise in same-facility revenues. Despite these gains, the company reported a net loss of $35.9 million for the quarter. Adjusted EBITDA was slightly lower at $102.3 million compared to the prior year. The…
BridgeBio Pharma announced that primary results from its Phase 3 CALIBRATE trial of encaleret for autosomal dominant hypocalcemia type 1 (ADH1) will be presented at the 2026 European Congress of Endocrinology. Additional presentations on genetic testing and disease monitoring related to hypoparathyroidism and ADH1 will also be shared, highlighting …
Compass Therapeutics reported positive first quarter 2026 financial results and highlighted significant progress in its oncology pipeline. The Phase 2/3 study of tovecimig (DLL4 x VEGF-A bispecific antibody) combined with paclitaxel showed statistically significant improvements in progression-free survival and overall response rate in biliary tract…
Kura Oncology, a biopharmaceutical company specializing in precision cancer medicines, will report its first quarter 2026 financial results on May 12, 2026. The company will host a webcast and conference call to discuss the results and provide a corporate update. Kura is known for KOMZIFTI, an FDA-approved oral menin inhibitor for certain leukemia …
Intellia Therapeutics, a clinical-stage biopharmaceutical company focused on CRISPR gene editing, will participate in investor fireside chats at three major healthcare conferences in May and June 2026. The events will be webcast live, offering investors insights into the company's mission to develop potentially curative treatments targeting the roo…
Exodus Movement, Inc., a self-custodial payments and cryptocurrency platform, announced it will release its financial results for the first quarter of 2026 on May 12, 2026, after market close. The company will host an earnings webcast that day and provide supplementary materials on its website. Founded in 2015 and headquartered in Omaha, Nebraska, …
